Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.

Q. Laurent-Badr; C. Barbe; M. Brugel; V. Hautefeuille; J. Volet; S. Grelet; E. Desot; D. Botsen; S. Deguelte; A. Pitta; N. Abdelli; M. Brasseur; L. de Mestier; C. Neuzillet; O. Bouché

doi:10.1016/j.dld.2020.03.014

Journal Articles Digestive and Liver Disease Year : 2020

Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.

, , , , , (1) , , , , , , , (2) , (3, 4) ,

1
2
3
4

Q. Laurent-Badr

Function : Correspondent author

C. Barbe

Function : Author

M. Brugel

Function : Author

V. Hautefeuille

Function : Author

J. Volet

Function : Author

S. Grelet

Function : Author

Hollings Cancer Center [Charleston]

E. Desot

Function : Author

D. Botsen

Function : Author

S. Deguelte

Function : Author

A. Pitta

Function : Author

N. Abdelli

Function : Author

M. Brasseur

Function : Author

L. de Mestier

Function : Author

Hôpital Beaujon [AP-HP]

C. Neuzillet

Function : Author

Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil

Institut Curie [Paris]

O. Bouché

Function : Author

Domains

Life Sciences [q-bio]

Fichier principal

S159086582030116X.pdf (883.01 Ko)

Origin : Files produced by the author(s)

Accord Elsevier CCSD : Connect in order to contact the contributor

https://hal.science/hal-03490942

Submitted on : Monday, August 22, 2022-12:17:07 PM

Last modification on : Tuesday, October 18, 2022-4:31:05 AM

Long-term archiving on: Wednesday, November 23, 2022-9:17:09 PM

Dates and versions

hal-03490942 , version 1 (22-08-2022)

Licence

Attribution - NonCommercial - CC BY 4.0

Identifiers

HAL Id : hal-03490942 , version 1
DOI : 10.1016/j.dld.2020.03.014
PII : S1590-8658(20)30116-X

Cite

Q. Laurent-Badr, C. Barbe, M. Brugel, V. Hautefeuille, J. Volet, et al.. Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.. Digestive and Liver Disease, 2020, 52, pp.658 - 667. ⟨10.1016/j.dld.2020.03.014⟩. ⟨hal-03490942⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

FNCLCC CURIE UVSQ PSL UNIV-PARIS-SACLAY

22 View

7 Download

Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.

Domains

Dates and versions

Licence

Identifiers

Cite

Export

Collections

Altmetric

Share